Anakinra shows promise for hidradenitis suppurativa

The results of a pilot study suggest that the interleukin-1(IL-1) receptor antagonist anakinra may be a potential treatment option for hidradenitis suppurativa (HS). The cause of HS – a chronic skin disorder affecting areas with apocrine glands leading to nodules, inflammation, rupture, and...
Source: Skin and Allergy News - Category: Dermatology Source Type: news